New York is poised to see its first initial public offering by a Chinese company in seven months amid signs the city could see a new flurry of such listings, Nikkei reported.
Healthcare supplies maker Meihua International Medical Technologies is on track this week to price its debut share sale, which would raise up to $57.5 million, the report said, citing the New York Stock Exchange’s online IPO hub. New US stocks usually start to trade a day after pricing and eight Chinese companies have filed initial public registration statements, called F-1s, with the US Securities and Exchange Commission in the six weeks since December 30.
Read the full report: Nikkei.
ALSO READ:
Bankers Urge China IPOs to Shun NYSE for HK After Didi Saga: FT
Yatsen Holding revives China IPO sentiment
China Regulator Approves IPO for Chip Unit of Carmaker BYD